» Articles » PMID: 30465055

Rutin and Orlistat Produce Antitumor Effects Via Antioxidant and Apoptotic Actions

Overview
Specialty Pharmacology
Date 2018 Nov 23
PMID 30465055
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer is a broad term used to describe a large number of diseases characterized by uncontrolled cell proliferation that leads to tumor production. Cancer is associated with mutations in genes controlling proliferation and apoptosis, oxidative stress, fatty acid synthase (FAS) expression, and other mechanisms. Currently, most antineoplastic drugs have severe adverse effects and new effective and safe drugs are needed. This study aims to investigate the possible anticancer activity of rutin and orlistat which are both safely used clinically in humans against two breast cancer models (in vivo EAC and in vitro MCF7) and the pancreatic cancer cell line (PANC-1). Our results have shown that both rutin and orlistat exerted an in vivo anticancer activity as evidenced by the decrease in tumor volume, CEA level, cholesterol content, FAS, and the exerted antioxidant action (reduced MDA level and increased GSH content) and through histopathological examination. In addition, both were cytotoxic to MCF-7 and Panc-1 cell lines by promoting apoptosis. In conclusion, the anticancer activity of rutin and orlistat makes them promising candidates for cancer treatment alone or in combination with other anticancer drugs specially that they are used clinically with an acceptable safety profile.

Citing Articles

Promotion Mechanisms of Stromal Cell-Mediated Lung Cancer Development Within Tumor Microenvironment.

Wu S, Hu Y, Sui B Cancer Manag Res. 2025; 17:249-266.

PMID: 39957904 PMC: 11829646. DOI: 10.2147/CMAR.S505549.


L. (date palm) fruit extracts and fractions exhibit anti-proliferative activity against human pancreatic cancer cell lines.

Al Alawi R, Hoheisel J, Alhamdani M, Baqi Y Heliyon. 2025; 11(3):e42274.

PMID: 39944344 PMC: 11815707. DOI: 10.1016/j.heliyon.2025.e42274.


Methanolic Leaves Extract of Inhibits Cell Proliferation and Migration of HER2-Positive Breast Cancer via p38 MAPK Signaling Pathway.

Saeed S, Hassan A, Suliman A, Moustafa A, Alali F Int J Mol Sci. 2025; 26(2).

PMID: 39859369 PMC: 11765879. DOI: 10.3390/ijms26020654.


Potential Protective Effect of Orlistat: A Formulation of Nanocrystals Targeting Inflammation, Oxidative Stress, and Apoptosis in an Experimental Model of Doxorubicin-Induced Cardiotoxicity.

Alsunbul M, El-Masry T, El Zahaby E, Gaballa M, El-Nagar M Pharmaceutics. 2024; 16(11).

PMID: 39598480 PMC: 11597902. DOI: 10.3390/pharmaceutics16111356.


The Cytotoxic Activity and Metabolic Profiling of Mart. et Gal.

Zhang J, Gao W, Jahan I, Zhai R, Yao K, Yan J Molecules. 2024; 29(17).

PMID: 39275063 PMC: 11396782. DOI: 10.3390/molecules29174216.


References
1.
Abu-Zeid M, Hori H, Nagasawa H, Uto Y, INAYAMA S . Studies of methyl 2-nitroimidazole-1-acetohydroxamate (KIN-804) 1: effect on free radical scavenging system in mice bearing Ehrlich ascites carcinoma. Biol Pharm Bull. 2000; 23(2):190-4. DOI: 10.1248/bpb.23.190. View

2.
Adwas A, Elkhoely A, Kabel A, Abdel-Rahman M, Eissa A . Anti-cancer and cardioprotective effects of indol-3-carbinol in doxorubicin-treated mice. J Infect Chemother. 2015; 22(1):36-43. DOI: 10.1016/j.jiac.2015.10.001. View

3.
Ahmed L, El-Maraghy S . Nicorandil ameliorates mitochondrial dysfunction in doxorubicin-induced heart failure in rats: possible mechanism of cardioprotection. Biochem Pharmacol. 2013; 86(9):1301-10. DOI: 10.1016/j.bcp.2013.07.005. View

4.
Ahmed H, Hegazi M, Abd-Alla H, Eskander E, Ellithey M . Antitumour and antioxidant activity of some Red Sea seaweeds in Ehrlich ascites carcinoma in vivo. Z Naturforsch C J Biosci. 2011; 66(7-8):367-76. DOI: 10.1515/znc-2011-7-808. View

5.
Alonso-Castro A, Dominguez F, Garcia-Carranca A . Rutin exerts antitumor effects on nude mice bearing SW480 tumor. Arch Med Res. 2013; 44(5):346-51. DOI: 10.1016/j.arcmed.2013.06.002. View